ArticleCancer cell international2026
The novel oleanolic acid derivative ZQL-4c modulates trastuzumab resistance in HER2+ breast cancer by inhibiting SCD-mediated lipid metabolism disorders.
Yiwen Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.